Rocket Pharmaceuticals, Inc. (RCKT)
3.74
+0.29
(+8.41%)
USD |
NASDAQ |
Feb 19, 16:00
3.71
-0.03
(-0.80%)
Pre-Market: 09:16
Rocket Pharmaceuticals EPS Diluted (Quarterly) : -0.4511 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Artiva Biotherapeutics, Inc. | -0.8794 |
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.33M |
| Total Expenses (Quarterly) | 50.33M |
| Enterprise Value | 207.04M |
| Earnings Yield | -60.10% |
| Normalized Earnings Yield | -59.49 |